TALDO1

Across TCGA pan-cancer cohorts, TALDO1 mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of TALDO1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where TALDO1 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types TALDO1 is over-expressed in tumor, although a few such as PDAC and CCRCC show the opposite, repressed pattern.

COAD, LSCC, and PDAC are the cancer types where TALDO1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TALDO1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	II,III,IV	+0.404	<.001	10	view →
LSCC	All	II,III,IV	+0.240	<.001	6	view →
PDAC	Male	All	−0.235	.001	4	view →
CCRCC	Male	All	−0.126	<.001	4	view →
LUAD	Female	All	+0.304	.001	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

TALDO1–COAD

Open the COAD breakdown →